Model Portfolios | Institutional | News | Contact

AGNG

Aging Population ETF

Reasons to Consider AGNG

Long-Term Growth Potential

Humans are living longer than ever, with forecasts suggesting the global population of adults age 60+ could double to more than 2bn by 2050.¹

Demographics Drive Consumption

With a ballooning senior population, particularly in western countries, we expect to see waves of innovation catering to their distinct consumer preferences.

Unconstrained Approach

The Aging Population theme is a global trend, affecting a wide range of industries. AGNG invests accordingly, offering exposure to companies regardless of sector or geographic classification.

¹WHO, Oct 2021

Key Information As of 11/22/23

Inception Date	05/09/16
Total Expense Ratio	0.50%
Net Assets	$53.27 million
NAV	$26.50
Fact Sheet	View the document

ETF Summary

The Global X Aging Population ETF (AGNG) seeks to invest in companies positioned to serve the world’s growing senior population through exposure to health care, pharmaceuticals, senior living facilities and other sectors that contribute to increasing lifespans and extending quality of life in advanced age.

ETF Objective

The Global X Aging Population ETF (AGNG) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Indxx Aging Population Thematic Index.

Trading Details As of 11/22/23

Ticker	AGNG
Bloomberg Index Ticker	ILNGRNT
CUSIP	37954Y772
ISIN	US37954Y7720
Primary Exchange	Nasdaq
Shares Outstanding	2,010,000
Number of Holdings	93
30-Day Median Bid-Ask Spread	0.35%

Distributions As of 11/22/23

30-Day SEC Yield	1.08%
Distribution Frequency	Semi-Annually

ETF Prices As of 11/22/23

NAV	$26.50	Daily Change	$0.04	0.15%
Market Price	$26.50	Daily Change	$0.14	0.53%

As of recent (09/30/23) As of recent (09/30/23)	Fund NAV	Market Price	Index
1 Year	11.72%	11.43%	12.03%
3 Years	1.24%	1.12%	1.47%
5 Years	3.89%	3.71%	4.10%
Since Inception	8.36%	8.61%	8.64%
1 Year	0.55%	0.72%	0.82%
3 Years	1.24%	1.24%	1.45%
5 Years	5.78%	5.68%	6.00%
Since Inception	7.60%	7.89%	7.88%
Year-to-Date	0.05%	-0.14%	0.29%
1 Month	-4.46%	-4.55%	-4.43%
3 Months	-6.11%	-6.44%	-6.00%
Since Inception	81.16%	84.28%	84.66%
Year-to-Date	-4.43%	-4.32%	-4.21%
1 Month	-4.48%	-4.19%	-4.48%
3 Months	-10.99%	-10.65%	-10.93%
Since Inception	73.04%	76.55%	76.38%

Performance is shown on a total return basis (i.e., with gross income reinvested, where applicable). Cumulative return is the aggregate amount that an investment has gained or lost over time. Annualized return is the average return gained or lost by an investment each year over a given time period.

The performance data quoted represents past performance. Past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than their original cost and current performance may be lower or higher than the performance quoted. High short-term performance, when observed, is unusual and investors should not expect such performance to be repeated.

Net Assets (%)	Ticker	Name	SEDOL	Market Price ($)	Shares Held	Market Value ($)
5.07	LLY	ELI LILLY & CO	2516152	601.10	4,531	2,723,584.10
4.28	4519 JP	CHUGAI PHARMA CO	6196408	33.93	67,840	2,301,945.22
4.01	NOVOB DC	NOVO NORDISK A/S-B	BP6KMJ1	105.17	20,512	2,157,288.51
3.79	WELL	WELLTOWER INC	BYVYHH4	89.62	22,757	2,039,482.34
3.41	BSX	BOSTON SCIENTIFIC CORP	2113434	55.63	32,974	1,834,343.62
3.34	AMGN	AMGEN INC	2023607	265.46	6,758	1,793,978.68
3.29	SGEN	SEAGEN INC	BLPK4D2	214.45	8,234	1,765,781.30
3.22	ALC SW	ALCON INC	BJT1GR5	73.32	23,631	1,732,698.83
3.18	SYK	STRYKER CORP	2853688	293.64	5,824	1,710,159.36
3.07	DXCM	DEXCOM INC	B0796X4	112.95	14,609	1,650,086.55
3.06	MDT	MEDTRONIC PLC	BTN1Y11	78.97	20,819	1,644,076.43
3.03	REGN	REGENERON PHARMACEUTICALS	2730190	798.30	2,041	1,629,330.30
2.90	JNJ	JOHNSON & JOHNSON	2475833	152.50	10,225	1,559,312.50
2.73	AZN	ASTRAZENECA PLC-SPONS ADR	2989044	64.50	22,714	1,465,053.00
2.69	ABBV	ABBVIE INC	B92SR70	138.67	10,439	1,447,576.13
2.53	EW	EDWARDS LIFESCIENCES CORP	2567116	67.90	20,062	1,362,209.80
2.52	BIIB	BIOGEN INC	2455965	231.95	5,850	1,356,907.50
2.24	RO SW	ROCHE HOLDING AG-BR	7108918	286.22	4,210	1,204,971.37
2.22	BMY	BRISTOL-MYERS SQUIBB CO	2126335	49.76	23,975	1,192,996.00
1.75	ZBH	ZIMMER BIOMET HO	2783815	113.43	8,299	941,355.57
1.74	4543 JP	TERUMO CORP	6885074	31.99	29,292	937,116.73
1.62	STMN SW	STRAUMANN HOLDING AG-REG	BQ7ZV06	138.52	6,272	868,769.97
1.60	4503 JP	ASTELLAS PHARMA INC	6985383	12.15	70,889	861,545.19
1.53	GMAB DC	GENMAB A/S	4595739	316.68	2,601	823,672.58
1.42	BGNE	BEIGENE LTD-ADR	BYYWPW6	184.72	4,134	763,611.81
1.39	068270 KS	CELLTRION INC	B0C5YV1	128.60	5,800	745,879.62
1.33	VTR	VENTAS INC	2927925	45.11	15,816	713,459.76
1.27	SOON SW	SONOVA HOLDING AG-REG	7156036	283.84	2,406	682,907.30
1.08	UCB BB	UCB SA	5596991	76.16	7,643	582,121.54
0.96	PODD	INSULET CORP	B1XGNW4	187.95	2,752	517,238.40
0.88	INCY	INCYTE CORP	2471950	53.74	8,776	471,622.24
0.86	EXAS	EXACT SCIENCES CORP	2719951	65.99	7,016	462,985.84
0.86	FME GR	FRESENIUS MEDICA	5129074	40.04	11,501	460,503.02
0.83	3692 HK	HANSOH PHARMACEU	BJYKB72	1.90	235,043	445,762.11
0.83	SN/ LN	SMITH & NEPHEW PLC	0922320	12.92	34,403	444,574.59
0.82	COH AU	COCHLEAR LTD	6211798	170.46	2,592	441,844.95
0.79	NBIX	NEUROCRINE BIOSC	2623911	112.17	3,800	426,246.00
0.78	UTHR	UNITED THERAPEUTICS CORP	2430412	231.13	1,819	420,425.47
0.75	TFX	TELEFLEX INC	2881407	219.95	1,842	405,147.90
0.69	DEMANT DC	DEMANT A/S	BZ01RF1	40.85	9,085	371,156.42
0.66	DVA	DAVITA INC	2898087	99.26	3,579	355,251.54
0.55	OHI	OMEGA HEALTHCARE	2043274	32.03	9,270	296,918.10
0.52	EXEL	EXELIXIS INC	2576941	21.68	12,829	278,132.72
0.52	AMP IM	AMPLIFON SPA	B14NJ71	31.09	8,930	277,645.94
0.46	BPMC	BLUEPRINT MEDICINES CORP	BWY52P3	68.45	3,589	245,667.05
0.45	ENSG	ENSIGN GROUP INC/THE	B1YWPP8	109.60	2,182	239,147.20
0.41	NHC	NATIONAL HEALTHCARE CORP	2139731	76.90	2,885	221,856.50
0.40	HALO	HALOZYME THERAPEUTICS INC	2975098	40.38	5,364	216,598.32
0.40	GKOS	GLAUKOS CORP	BYMWL19	63.12	3,426	216,249.12
0.40	BKD	BROOKDALE SR	B0PZN33	5.26	40,477	212,909.02
0.39	SBRA	SABRA HEALTH CAR	B5NLBP6	14.51	14,283	207,246.33
0.39	CSH-U CN	CHARTWELL RETIRE	B8S8C94	7.87	26,299	207,081.79
0.38	ACAD	ACADIA PHARMACEU	2713317	22.29	9,192	204,889.68
0.37	AMED	AMEDISYS INC	2024332	93.75	2,136	200,250.00
0.36	ITGR	INTEGER HOLDINGS CORP	BD06LM7	89.52	2,148	192,288.96
0.36	AGL	AGILON HEALTH INC	BLR4TK4	11.80	16,262	191,891.60
0.34	NHI	NATL HEALTH INVESTORS INC	2626125	54.30	3,337	181,199.10
0.34	6600 HK	SCICLONE PHARMAC	BMX5ZW2	1.56	115,500	179,921.09
0.33	EKTAB SS	ELEKTA AB-B SHS	B0M42T2	8.55	20,423	174,636.44
0.32	LIVN	LIVANOVA PLC	BYMT0J1	44.12	3,912	172,597.44
0.31	2186 HK	LUYE PHARMA GROUP LTD	BNQ4GF3	0.50	334,724	168,365.97
0.31	AGIO	AGIOS PHARMACEUTICALS INC	BCBVTX1	22.33	7,505	167,586.65
0.31	SIA CN	SIENNA SENIOR LIVING INC	BWTYXH4	7.99	20,651	165,037.95
0.31	8086 JP	NIPRO CORP	6641599	7.49	21,971	164,519.81
0.30	RYM NZ	RYMAN HEALTHCARE LTD	6161525	3.29	49,649	163,155.09
0.30	MMSI	MERIT MEDICAL SYSTEMS INC	2580555	72.32	2,256	163,153.92
0.30	LTC	LTC PROPERTIES INC	2498788	32.53	4,902	159,462.06
0.30	GN DC	GN STORE NORD A/S	4501093	21.95	7,241	158,961.87
0.29	AED BB	AEDIFICA	B1G5XP1	63.23	2,448	154,794.31
0.29	PHM SM	PHARMA MAR SA	BMW2GT8	42.34	3,622	153,346.97
0.28	TBPH	THERAVANCE BIOPHARMA INC	BMNDK09	10.47	14,143	148,077.21
0.27	MNKD	MANNKIND CORP	BF081J4	3.62	40,415	146,302.30
0.27	145720 KS	DENTIUM CO LTD	BF07GJ6	97.98	1,462	143,251.04
0.26	DCPH	DECIPHERA PHARMA	BZ1LFB2	12.24	11,254	137,748.96
0.24	ALEC	ALECTOR INC	BJ4LDC4	5.02	25,572	128,371.44
0.24	1302 HK	LIFETECH SCIENTIFIC CORP	BV9FKS0	0.31	414,492	126,582.74
0.24	ATEC	ALPHATEC HOLDINGS INC	BD60BG7	11.87	10,659	126,522.33
0.23	DNLI	DENALI THERAPEUTICS INC	BD2B4V0	18.41	6,815	125,464.15
0.23	ANGO	ANGIODYNAMICS INC	B00CR04	6.98	17,882	124,816.36
0.23	853 HK	MICROPORT SCIENTIFIC CORP	B676TW7	1.64	73,602	120,887.38
0.21	9229 JP	SUNWELS CO LTD	BNTYNB5	16.71	6,710	112,113.84
0.20	1789 HK	AK MEDICAL HOLDINGS LTD	BFD6SZ0	0.87	125,389	108,925.48
0.20	1858 HK	BEIJING CHUNLI-H	BVVPXP6	1.74	62,466	108,688.80
0.19	EMBC	EMBECTA CORP	BMXWYR1	17.49	5,864	102,561.36
0.19		OTHER PAYABLE & RECEIVABLES		1.00	100,484	100,484.42
0.17	AMRN	AMARIN CORP PLC -ADR	2301938	0.78	119,447	93,503.11
0.14	2500 HK	VENUS MEDTECH -H	BL6V047	0.72	106,440	76,757.81
0.11		CASH		1.00	56,544	56,543.51
0.11	SGHT	SIGHT SCIENCES INC	BN2T5Q6	3.10	18,183	56,367.30
0.10	CLARI FP	CLARIANE SE	B1HKRM0	2.57	21,581	55,482.40
0.10	NVCR	NOVOCURE LTD	BYSS4X4	12.47	4,135	51,563.45
0.06	SILK	SILK ROAD MEDICAL INC	BGHVXJ7	8.16	4,103	33,480.48
0.02	CANO	CANO HEALTH INC	BNV0C14	7.77	1,193	9,272.95
0.01	FGEN	FIBROGEN INC	BSDRYR8	0.49	8,562	4,152.57
0.01		EURO		1.09	2,269	2,482.10
0.00		RADIUS HEALTH INC - CVR	2KFF9T0	0.00	19,104	0.00
0.00		JAPANESE YEN		0.01	-2	-0.01

Holdings are subject to change. "Cash" denotes U.S. dollars.

Exposure As of 10/31/23

	Sector	Weight (%)
	Health Care	92.9
	Real Estate	7.1

Source: new windowAltaVista Research, LLC

	Industry	Weight (%)
	Medical Specialties	33.6
	Pharmaceuticals: Major	24.8
	Biotechnology	21.8
	Real Estate Investment Trusts	7.5
	Pharmaceuticals: Other	7.4
	Medical/Nursing Services	2.9
	Hospital/Nursing Management	1.4
	Electrical Products	0.4
	Telecommunications Equipment	0.2

Source: new windowAltaVista Research, LLC

	Country	Weight (%)
	United States	59.2
	Switzerland	8.3
	Japan	7.9
	Denmark	6.3
	Britain	4.1
	China	4.1
	Ireland	3.1
	South Korea	1.5
	Belgium	1.4
	Australia	0.8
	Germany	0.8
	Other	2.5

Source: new windowAltaVista Research, LLC

All Sector, Industry and Geographic breakdowns, where provided, are based on equity positions held by the ETF and exclude cash, currencies, and other holdings.

ETF Characteristics As of 11/22/23

Return on Equity	12.60%
Weighted Avg. Market Cap	100,295 M
	2022	2023
Price-to-earnings	25.68	26.45
Price-to-book value	3.43	3.26

Source: new windowAltaVista Research, LLC

ETF Risk Stats As of 10/31/23

Versus	Beta
S&P 500	0.68
NASDAQ-100	0.48
MSCI EAFE	0.69
MSCI Emg. Mkts	0.51
Standard Deviation	15.90%

Source: new windowAltaVista Research, LLC

ETF Research

ETF Documents

Latest Premium / Discount As of 11/22/23

NAV	$26.50
Market Price	$26.50
Premium / (Discount)	$0.00

Current View 2023 Q4 As of 11/22/23

Days at Premium	7
Days at NAV	0
Days at Discount	31
Greatest Premium	0.16%
Greatest Discount	-0.56%

Daily Premium / Discount History As of 11/22/23

Hover over the chart points for details

View Chart Explanation

Download Chart Data (.CSV)

How can the Fund trade at a premium/discount to its NAV?

The primary explanation is that timing discrepancies can arise between the NAV and the trading price of the Fund. Since shares of the Fund trade on the open market, prices are affected by the constant flow of information received by investors, corporations and financial institutions. Depending on how this changing information affects investor sentiment, shares of the Fund may deviate slightly from the value of the Fund's underlying assets. The NAV of the Fund is only calculated once a day (normally at 4:00 p.m. eastern time). As a result, shareholders may pay more than NAV when they buy Fund shares and receive less than NAV when they sell those shares, because shares are purchased and sold at current market prices. However, due to the creation and redemption process that is unique to ETFs, market makers are able to minimize these deviations from NAV by taking advantage of arbitrage opportunities.

What causes these time discrepancies?

Close of Trading Times. Although both the NAV and the daily market price of the Fund are generally calculated based on prices at the closing time of the exchange (generally 4:00 p.m. eastern time), slight differences in this timing may cause discrepancies.

Time of Last Trade. Trading of Global X funds generally takes place during normal trading hours (9:30 a.m. to 4:00 p.m. eastern time). However, it is important to note that the last trade - from which the closing price is determined - may not occur at exactly 4:00 p.m. eastern time. Therefore, changing market sentiment during the time difference may cause the NAV to deviate from the closing price.

International Holdings. The premiums and discounts for funds with significant holdings in international markets may be less accurate due to the different closing times of various international markets. Because the Funds trade during U.S. market hours while the underlying securities may not, the time lapse between the markets can result in differences between the NAV and the trading price.

Investing involves risk, including the possible loss of principal. The investable universe of companies in which AGNG may invest may be limited. The Fund invests in securities of companies engaged in Healthcare, Pharmaceutical, Biotechnology and Medical Device sectors. These sectors can be affected by government regulations, expiring patents, rapid product obsolescence, and intense industry competition. International investments may involve risk of capital loss from unfavorable fluctuation in currency values, from differences in generally accepted accounting principles or from social, economic or political instability in other nations. AGNG is non-diversified.

Shares of ETFs are bought and sold at market price (not NAV) and are not individually redeemed from the Fund. Brokerage commissions will reduce returns. Beginning October 15, 2020, market price returns are based on the official closing price of an ETF share or, if the official closing price isn’t available, the midpoint between the national best bid and national best offer (“NBBO”) as of the time the ETF calculates current NAV per share. Prior to October 15, 2020, market price returns were based on the midpoint between the Bid and Ask price. NAVs are calculated using prices as of 4:00 PM Eastern Time. The returns shown do not represent the returns you would receive if you traded shares at other times. Indices are unmanaged and do not include the effect of fees, expenses or sales charges. One cannot invest directly in an index.

Carefully consider the Fund’s investment objectives, risks, and charges and expenses before investing. This and other information can be found in the Fund’s summary or full prospectuses. Please read the prospectus carefully before investing.

Global X Management Company LLC serves as an advisor to Global X Funds. The Funds are distributed by SEI Investments Distribution Co. (SIDCO), which is not affiliated with Global X Management Company LLC or Mirae Asset Global Investments. Global X Funds are not sponsored, endorsed, issued, sold or promoted by Indxx, nor does Indxx make any representations regarding the advisability of investing in the Global X Funds. Neither SIDCO, Global X nor Mirae Asset Global Investments are affiliated with Indxx.

AGNG traded under the ticker LNGR from inception until April 1, 2021.

AGNG

Aging Population ETF

Reasons to Consider AGNG

Long-Term Growth Potential

Demographics Drive Consumption

Unconstrained Approach

Key Information As of 11/22/23

ETF Summary

ETF Objective

Trading Details As of 11/22/23

Distributions As of 11/22/23

ETF Prices As of 11/22/23

Performance History

Top Holdings As of 11/24/23

Exposure As of 10/31/23

ETF Characteristics As of 11/22/23

ETF Risk Stats As of 10/31/23

ETF Research

The Genomic Medicine Revolution

ASCO Annual Meeting 2023: Precision Oncology Achieving Widespread Adoption

Diabetes Management: Massive Addressable Market Spurs Innovative Solutions

ETF Documents